Tag: Technology

Study: Adjuvant nivolumab reduces risk of death, lung cancer recurrence

Editor's Note An analysis of two phase-III trials showed adjuvant administration of nivolumab (Opdivo) plus chemotherapy reduces the risk of recurrence or death in patients with resectable non-small cell lung cancer (NSCLC) by 40% compared to neoadjuvant nivolumab plus chemotherapy alone, Medpage Today reported September 9. "With the caveat that…

Read More

By: Matt Danford
September 18, 2024
Share

FDA designates Class 1 recall for infusion system components

Editor's Note The US Food and Drug Administration (FDA) has designated Fresenius Kabi’s recall of certain Ivenix infusion system components as Class 1, the most severe category indicating risk of serious injury or death. According to the agency’s September 16 announcement, the recalled items consist of a certain lot (3010538)…

Read More

By: Matt Danford
September 16, 2024
Share

Study: Right-sized donor livers scarce for female cancer patients

Editor's Note A recent study in JAMA Surgery showed women with hepatocellular carcinoma (HCC) were 8% less likely than men to receive a liver transplant and 6% more likely to die or be removed from the waitlist, Healio reported September 9.    The study, which analyzed 31,725 adults waitlisted for…

Read More

By: Matt Danford
September 13, 2024
Share

NYU Langone surgeons complete first fully robotic lung transplant in US

Editor's Note Surgeons at NYU Langone Health used a da Vinci X robotic system throughout an entire lung transplant procedure for the first time in the US and the third time in the world, DotMed reported September 11. Led by Dr. Stephanie Chang, the surgery offered a fast, minimally invasive…

Read More

By: Matt Danford
September 13, 2024
Share

Researchers in Zurich, Hong Kong celebrate remote surgery milestone with successful pig endoscopy

Editor's Note Surgeons used a remote control to perform a magnetic endoscopy on a live pig more than 9,300 km (nearly 6,000 miles) away, Medical Xpress reported August 26. According to the article, researchers at ETH Zurich and The Chinese University of Hong Kong collaborated in the procedure, with the…

Read More

By: Matt Danford
September 11, 2024
Share

World’s first whole-eye, partial-face transplant patient returns to daily life

Editor's Note Aaron James says he’s “pretty much back to being a normal guy, doing normal things” a year after undergoing the world’s first whole-eye and partial-face transplant at NYU Langone Health, according to a September 9 report from the academic medical center. The transplant restored essential facial functions, and…

Read More

By: Matt Danford
September 10, 2024
Share

FDA announces Class 1 recalls for laryngoscopes, ventilators

Editor's Note Recalls of certain devices and instruction updates for others prompted the US Food and Drug Administration (FDA) to issue Class 1 recalls—the most severe category indicating risk of serious injury or death—for two groups of products: Medtronic’s McGrath MAC and MAC EMS Video Laryngoscopes and Breas Medical’s Vivo…

Read More

By: Matt Danford
September 6, 2024
Share

Study: bariatric surgery beats medication for hypertension control

Editor's Note Findings to be presented at the American Heart Association's Hypertension Scientific Sessions 2024 suggest bariatric surgery may offer more effective long-term control of high blood pressure for people with obesity compared to medications and lifestyle changes, according to a September 5 report in News Medical. According to the…

Read More

By: Matt Danford
September 6, 2024
Share

Iranian group intensifies cyberattacks on US healthcare

Editor's Note Cyberattacks in August 2024 are the latest examples of a specific Iranian group intensifying efforts against US organizations since 2017, Healthcare IT News reported September 3. Citing an advisory issued by the Federal Bureau of Investigation (FBI), Cybersecurity and Infrastructure Security Agency (CISA), and the Department of Defense…

Read More

By: Matt Danford
September 5, 2024
Share

FDA announces Class 1 recall for ventilator adapter assemblies

Editor's Note The US Food and Drug Administration (FDA) designated Baxter’s recall of certain Single Patient Use Circuits and Blue Ventilator Adapter Assemblies as Class 1, the most severe recall category indicating significant risk of injury or death. The Single Patient Use Circuit and Blue Adapter Assembly are patient circuit…

Read More

By: Matt Danford
September 5, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat